Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Upon the aberrant activation of oncogenes, normal cells can enter the cellular senescence program, a state of stable cell-cycle arrest, which represents an important barrier against tumour development in vivo. Senescent cells communicate with their environment by secreting various cytokines and growth factors, and it was reported that this 'secretory phenotype' can have pro- as well as anti-tumorigenic effects. Here we show that oncogene-induced senescence occurs in otherwise normal murine hepatocytes in vivo. Pre-malignant senescent hepatocytes secrete chemo- and cytokines and are subject to immune-mediated clearance (designated as 'senescence surveillance'), which depends on an intact CD4(+) T-cell-mediated adaptive immune response. Impaired immune surveillance of pre-malignant senescent hepatocytes results in the development of murine hepatocellular carcinomas (HCCs), thus showing that senescence surveillance is important for tumour suppression in vivo. In accordance with these observations, ras-specific Th1 lymphocytes could be detected in mice, in which oncogene-induced senescence had been triggered by hepatic expression of Nras(G12V). We also found that CD4(+) T cells require monocytes/macrophages to execute the clearance of senescent hepatocytes. Our study indicates that senescence surveillance represents an important extrinsic component of the senescence anti-tumour barrier, and illustrates how the cellular senescence program is involved in tumour immune surveillance…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the proinflammatory nature of the SASP, it is not surprising that senescent cells can attract immune cells, including destructive leukocytes of the innate and adaptive immune systems (131, 132, 135).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Among the cells that participate in the clearance of senescent cells are natural killer cells, macrophages, and T cells (131, 135, 139).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Senescent cells, presumably by virtue of SASP-derived factors, can stimulate the infiltration of leukocytes (93, 131, 132), which produce reactive toxic moieties that can cause DNA damage.”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Another function appears to be the stimulation of a local immune reaction to eliminate oncogene-expressing cells, both those cells that have undergone oncogene-induced senescence and those oncogene-transformed cells that have bypassed or escaped senescence (131).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“The surveillance and clearance of senescent cells by the immune system is necessary in order to limit tumorigenesis in premalignant lesions and following cancer therapy155,156,159.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [156]
39 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
Self-citationKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Khwaja, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2783 · Cited by 1,039
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538
Frid, M. G., Brunetti, J. A., Burke, D. L., Carpenter, T. C., Davie, N. J., Reeves, J. T., Roedersheimer, M. T., van Rooijen, N., & Stenmark, K. R. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050599 · Cited by 449
Silva, M. T. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809549 · Cited by 322
Cited by
Items 801–900 of 1,009
Senescence and Cancer: Role of Nitric Oxide (NO) in SASP
Mabrouk, N., Ghione, S., Laurens, V., Plenchette, S., Bettaïeb, A., & Paul, C. (2020) · Cancers · doi:10.3390/cancers12051145 · Cited by 31
“Adaptive immune cells such as the Th1 subclass of CD4+ cells are also involved in immune-mediated clearance in a model of OIS in murine hepatocytes [145].”
BackgroundChen, N., Nishio, N., Ito, S., Tanaka, Y., Sun, Y., & Isobe, K. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1690-8 · Cited by 28
“5 % bovine serum albumin (BSA) in PBS and chopped on ice into small 1-mm(3) pieces and digested as previously reported [22].”
MethodLi, D., Fu, J., Du, M., Zhang, H., Li, L., Cen, J., Li, W., Chen, X., Lin, Y., Conway, E. M., et al. (2016) · Hepatology · doi:10.1002/hep.28637 · Cited by 28
“6E,F), reinforcing the concept that synergistically boosting senescence and TNFa-triggered cell death is of value in treating HCC.”
InfluentialKohlhepp, M. S., Liu, H., Tacke, F., & Guillot, A. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1129831 · Cited by 27
“(Kang et al., 2011) Premalignant hepatocytes can enter a state of growth arrest termed oncogeneinduced senescence, a stress response to aberrant function of oncogenes, in which they acquire a secretory phenotype and release inflammatory cytokines and chemokines, amongst others CCL2 to recruit immune cells and initiate…”
BackgroundSelf-citationCellular Senescence, Inflammaging and Cardiovascular Disease
Zanders, L., Arifaj, D., Wagner, J. U. G., & Dimmeler, S. (2026) · Immunological Reviews · doi:10.1111/imr.70084 · Cited by 34
“Senescent cells have been re-ported to evade NK cell-mediated clearance [130].”
Immunosurveillance and immunoediting in MMTV-PyMT-induced mammary oncogenesis
Gross, E. T. E., Han, S., Vemu, P. L., Peinado, C. D., Maršala, M., Ellies, L. G., & Bui, J. D. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1268310 · Cited by 30
Sharma, R., & Padwad, Y. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101141 · Cited by 29
Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
Mittermeier, C., Konopa, A., & Muehlich, S. (2020) · Cells · doi:10.3390/cells9122540 · Cited by 31
Giannakoulis, V. G., Dubovan, P., Papoutsi, E., Kataki, A., & Koskinas, J. S. (2021) · Cancers · doi:10.3390/cancers13184732 · Cited by 30
“The latter implies that damaged cells manage to evade a normal checkpoint of proliferative arrest, which may subsequently promote carcinogenesis and/or cancer progression [39,43].”
BackgroundInfluentialCirculating Mitochondrial DNA and Inter-Organelle Contact Sites in Aging and Associated Conditions
Picca, A., Guerra, F., Calvani, R., Romanò, R., Coelho‐Júnior, H. J., Damiano, F. P., Bucci, C., & Marzetti, E. (2022) · Cells · doi:10.3390/cells11040675 · Cited by 31
Senotherapeutics in Cancer and HIV
Sánchez-Díaz, L., Espinosa-Sánchez, A., Blanco, J. R., & Carnero, A. (2022) · Cells · doi:10.3390/cells11071222 · Cited by 29
“Under physiological conditions, senescent cells are cleared by immune cells [38], but several authors have suggested that due to the decline in immune function in aged organisms, there is a decrease in the clearance of senescent cells [34].”
BackgroundEfficacy of immunotherapy in hepatocellular carcinoma: Does liver disease etiology have a role?
Pinto, E., Meneghel, P., Farinati, F., Russo, F. P., Pelizzaro, F., & Gambato, M. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.08.062 · Cited by 35
Vassilieva, I. O., Reshetnikova, G., Shatrova, A. N., Tsupkina, N. V., Харченко, М. В., Lp, A., Nikolsky, N. N., & Burova, E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.163 · Cited by 32
SMARCA4 regulates the NK-mediated killing of senescent cells
Reen, V., D’Ambrosio, M., Søgaard, P. P., Tyson, K., Leeke, B. J., Clément, I., Dye, I. C., Pombo, J., Kuba, A., Lan, Y., et al. (2025) · Science Advances · doi:10.1126/sciadv.adn2811 · Cited by 33
“…mM MgCl 2 /PBS (pH 6.0), and then incubated with X-Gal staining solu-tion {X-Gal (1 mg ml − 1 ; Thermo Fisher Scientific, 2737087), 5 mM K 3 [Fe(CN) 6 ], and 5 mM K 4 [Fe(CN) 6 ]} for 6 to 8 hours at 37°C. Bright-field images of cells were taken using the DP20 digital camera attached to the…”
InfluentialSelf-citationCardiovascular ageing: hallmarks, signaling pathways, diseases and therapeutic targets
Zheng, P., Yan, W., Ding, Y.-N., Zhang, Y., Chen, Z., Qian, J., & Ge, J. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02630-7 · Cited by 39
IMR90 ER:RAS: A Cell Model of Oncogene-Induced Senescence
Innes, A. J., & Gil, J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8931-7_9 · Cited by 30
Self-citationTumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner
Etxebeste-Mitxeltorena, M., del Rincón-Loza, I., & Martín-Antonio, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.717850 · Cited by 29
Pylypchuk, I. V., Suo, H., Chucheepchuenkamol, C., Jedicke, N., Lindén, P. A., Lindström, M. E., Manns, M. P., Sevastyanova, O., & Yevsa, T. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.817768 · Cited by 27
“HCC was induced using the intrahepatic overexpression of oncogenic NRAS stably delivered into the liver of mice in which tumor-suppressor Arf is disabled (p19 mice) via hydrodynamic tail vein injection, as previously described (Carlson et al., 2005; Kang et al., 2011).”
MethodSelf-citationHochnadel, I., Hoenicke, L., Petriv, N., Neubert, L., Reinhard, E., Hirsch, T., Alfonso, J. C. L., Suo, H., Longerich, T., Geffers, R., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02222-z · Cited by 27
“In line with previous studies, no tumors were detected at sampling in WT mice (data not shown) [11, 19].”
ResultSelf-citationMechanisms of Senescence and Anti-Senescence Strategies in the Skin
Konstantinou, E. K., Longange, E., & Kaya, G. (2024) · Biology · doi:10.3390/biology13090647 · Cited by 35
“Many different mouse models are used to investigate the role of senescent cells and the impact of their removal in aging and age-related diseases [148,149].”
BackgroundLiu, Y., Hawkins, O. E., Vilgelm, A. E., Pawlikowski, J. S., Ecsedy, J., Sosman, J. A., Kelley, M. C., & Richmond, A. J. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0293 · Cited by 30
“Accumulating evidence suggests that immune cells, including NK cells, T cells, macrophages and neutrophils, can clear premalignant cells and senescent tumor cells (18-20,35,36).”
BackgroundResultPacheco-Rivera, R., Fattel‐Fazenda, S., Arellanes‐Robledo, J., Silva-Olivares, A., Alemán‐Lazarini, L., Rodríguez‐Segura, M. A., Pérez‐Carreón, J. I., Villa‐Treviño, S., Shibayama, M., & Serrano‐Luna, J. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.11.011 · Cited by 27
“…studies investigating oncogene-induced senescence showed that impaired immune surveillance of pre-malignant senescent hepatocytes results in the development of murine HCC, indicating that senescence surveillance is important for tumor suppression in vivo (Kang et al., 2011; Lin et al., 2013).”
BackgroundChromosomal instability and pro-inflammatory response in aging
Barroso‐Vilares, M., & Logarinho, E. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111118 · Cited by 28
Ross, A. D. M., Cook, M. G., Chong, H., Hossain, M., Pandha, H., & Bennett, D. C. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12060 · Cited by 32
“…Hardev S. Pandha and Dorothy C. Bennett Submit your next paper to PCMR online at http://mc.manuscriptcentral.com/pcmr DOI: 10.1111/pcmr.12060 Volume 26, Issue 2, Pages 226–235 Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression”
InfluentialSenescence: A program in the road to cell elimination and cancer
Moiseeva, O., Guillon, J., & Ferbeyre, G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.017 · Cited by 25
Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells
Favaretto, G., Rossi, M. N., Cuollo, L., Laffranchi, M., Cervelli, M., Soriani, A., Sozzani, S., Santoni, A., & Antonangeli, F. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03695-5 · Cited by 26
“Macrophages also participate in the clearance of senescent cells [17, 18].”
BackgroundDhokia, V., Albati, A., Smith, H., Thomas, G., & Macip, S. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231066 · Cited by 26
Remodeling of tumor microenvironment by cellular senescence and immunosenescence in cervical cancer
He, Y., Qiu, Y., Yang, X., Lu, G., & Zhao, S. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.002 · Cited by 25
Yang, L. C., You, J., Yang, X., Jiao, R., Xu, J., Zhang, Y., Mi, W., Zhu, L., Ye, Y., Ren, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57334-3 · Cited by 30
“In this model, oncogenic NRas G12V acutely triggers senescence and SASP in hepatocytes at early time point, which activates immune surveillance for subsequent clearance of senescent hepatocytes at a later time point 46,63 .”
Dissecting the mechanisms of MASLD fibrosis in the era of single-cell and spatial omics
Colella, F., Henderson, N. C., & Ramachandran, P. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186421 · Cited by 31
“The innate immune system has been a major focus of scRNA-seq studies, particularly cells of the mono-cyte-macrophage lineage that strongly regulate fibrosis in preclinical models (98–101).”
Tao, Y., Yue, P., Miao, Y., Gao, S., Wang, B., Leng, S. X., Meng, X., & Zhang, H. (2020) · The Journal of Gene Medicine · doi:10.1002/jgm.3291 · Cited by 26
Raynard, C., Ma, X., Huna, A., Tessier, N., Massemin, A., Zhu, K., Flaman, J., Moulin, F., Goehrig, D., Médard, J., et al. (2022) · Aging Cell · doi:10.1111/acel.13632 · Cited by 26
“The SASP was reported to exert initial anti- tumoral effects in autocrine and paracrine manners, by blocking cell proliferation and by recruiting and activating immune cells to eliminate harmful and defective senescent cells (Acosta et al., 2008; Kuilman et al., 2008; Kang et al., 2011).”
BackgroundToll-like receptor 2 orchestrates a tumor suppressor response in non-small cell lung cancer
Millar, F. R., Pennycuick, A., Muir, M., Quintanilla, A., Hari, P., Freyer, E., Gautier, P. E., Meynert, A. M., Grimes, G. R., Salomo-Coll, C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111596 · Cited by 32
“…senescence-associated growth arrest in an autocrine manner (Acosta et al., 2008), induce senescence in neighboring cells (paracrine senescence) (Acosta et al., 2013), and orchestrate immune cell-mediated clearance of senescence cells (senescence surveillance) (Kang et al., 2011; Xue et al., 2007).”
InfluentialHedgehog Signaling: Implications in Liver Pathophysiology
Dutta, R. K., Jun, J. H., Du, K., & Diehl, A. M. (2023) · Seminars in Liver Disease · doi:10.1055/a-2187-3382 · Cited by 27
“” 75 However, some senescing cells mount adaptive responses that enable them to survive their own secretome and evade immune clearance.”
BackgroundSenescence and senolysis in cancer: The latest findings
Imawari, Y., & Nakanishi, M. (2024) · Cancer Science · doi:10.1111/cas.16184 · Cited by 26
“59 In the case of KRas G12V - driven lung neoplasia, the presence of the senescence markers p16 INK4a and SA-β - gal in precancerous lung adenomas and the absence of senescence markers and increased expression of the proliferation marker Ki67 in lung adenocarcinomas reflect the importance of OIS in…”
BackgroundDelineating the heterogeneity of senescence-induced-functional alterations in hepatocytes
Kumar, P., Hassan, M., Tacke, F., & Engelmann, C. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05230-2 · Cited by 31
Self-citationDai, H., Xu, D., Su, J., Jang, J., & Chen, Y. (2015) · Scientific Reports · doi:10.1038/srep12461 · Cited by 25
Prospects and Challenges for T Cell-Based Therapies of HCC
Woller, N., Engelskircher, S. A., Wirth, T. C., & Wedemeyer, H. H. (2021) · Cells · doi:10.3390/cells10071651 · Cited by 27
“During the pre-malignant phase of tumor development it has been shown that senescence surveillance is the driving force for the elimination of pre-cancerous and senescent hepatocytes with a secretory phenotype by CD4 T cells and macrophages [88].”
BackgroundSelf-citationAccumulation of annexin A5 at the nuclear envelope is a biomarker of cellular aging
Klement, K., Melle, C., Murzik, U., Diekmann, S., Norgauer, J., & Hemmerich, P. H. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.06.003 · Cited by 34
Yevsa, T., Kang, T.-W., & Zender, L. (2012) · OncoImmunology · doi:10.4161/onci.19128 · Cited by 25
“recent data from our laboratory suggest that the cellular senescence program also plays a crucial role in the induction of immune responses against pre-cancerous cells.(3) To mimic aberrant oncogene activation, which can occur in hepatocytes of chronically damaged human livers, we stably delivered oncogenic Nras into…”
BackgroundSelf-citationNavigating the complex role of senescence in liver disease
Li, Q.-J., & Wang, L. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003439 · Cited by 25
The Immune System and Cellular Senescence: A Complex Interplay in Aging and Disease
Ayoub, M., Jaoude, C. A., Ayoub, M., Hamadé, A., & Rima, M. (2025) · Immunology · doi:10.1111/imm.70036 · Cited by 31
“In the tumour microenvironment, impaired clearance allows cancer cells to persist and acquire additional mutations, creating therefore a pro-tumorigenic microenvironment [41]; while in organs like the liver, lungs and kidneys, this promotes fibrosis and organ dysfunction [33].”
Apicobasal Polarity Controls Lymphocyte Adhesion to Hepatic Epithelial Cells
Reglero-Real, N., Álvarez-Varela, A., Cernuda‐Morollón, E., Feito, J., Marcos‐Ramiro, B., Fernández‐Martín, L., Gómez-Lechón, M. J., Muntané, J., Sandoval, P., Majano, P. L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.007 · Cited by 24
Intersection of Inflammation and Senescence in the Aging Lung Stem Cell Niche
Allen, N. C., Reyes, N. S., Lee, J. Y., & Peng, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.932723 · Cited by 26
“In this case, the SCID mice were unable to clear the premalignant cells and the development of hepatocellular carcinoma was observed (Kang et al., 2011).”
BackgroundInfluentialTranscriptional Heterogeneity of Cellular Senescence in Cancer
Junaid, M., Lee, A., Kim, J., Park, T. J., & Lim, S. B. (2022) · Molecules and Cells · doi:10.14348/molcells.2022.0036 · Cited by 28
The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma
Ebrahimi, N., Far, N. P., Fakhr, S. S., Faghihkhorasani, F., Miraghel, S. A., Chaleshtori, S. R., Rezaei‐Tazangi, F., Beiranvand, S., Baziyar, P., Manavi, M. S., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115914 · Cited by 24
Yang, J., He, J., Feng, Y., & Xiang, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166440 · Cited by 29
Ji, P., Wang, C., Liu, Y., Guo, X., Liang, Y., Wei, J., Liu, Z., Gong, L., Yang, G., & Ji, G. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400945 · Cited by 26
Šímová, J., Sapega, O., Hornofova, T., Štěpánek, I., Kyjacová, L., Mikyšková, R., Indrová, M., Bieblová, J., Bubenik, J., Bártek, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10712 · Cited by 27
Su, Y., Wang, P., Shen, H., Sun, Z., Xu, C., Li, G., Tong, T., & Chen, J. (2018) · Journal of Cell Science · doi:10.1242/jcs.207217 · Cited by 24
“…response (DDR) (Rodier et al., 2009), the p38αMAPK (also known as MAPK14) (Freund et al., 2011), IL-1α (Orjalo et al., 2009), protein kinase D1 (PKD1; also known as PRKD1) (Wang et al., 2014) andGATA4 (Kang et al., 2015) have been implicated in SASP induction by modulating NF-κB activity.”
BackgroundSenescent cells: A new Achilles’ heel to exploit for cancer medicine?
Zhang, B., Lam, E. W. ‐., & Sun, Y. (2018) · Aging Cell · doi:10.1111/acel.12875 · Cited by 24
“…with the potential to boost immune surveillance by mounting specific inflammatory responses including those mediated by CD4+ T cells against antigens expressed in senescent cells, particularly those observed in premalignant lesions (Georgilis et al., 2018; Kang et al., 2011; Toso et al., 2014).”
BackgroundThe Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence
Liao, C., Xiao, Y., & Liu, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s285083 · Cited by 26
“ance of senescent hepatocytes, which contributes to liver cancer growth.(49) In addition, monocytes/macrophages are required for senescence surveillance mediated by CD4 T cells.”
BackgroundPetriv, N., Neubert, L., Vatashchuk, M., Timrott, K., Suo, H., Hochnadel, I., Huber, R., Petzold, C., Hrushchenko, A. O., Yatsenko, A. S., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1874159 · Cited by 25
“(OIS) precancerous liver disease (PLD) and HCC development, as established.(30,32) Briefly, DNA vectors (transposon and transposase) were prepared using the QIAGEN EndoFree Maxi Kit”
Self-citationWang, Y., Xu, Q., Sack, L. M., Kang, C., & Elledge, S. J. (2016) · Genes & Development · doi:10.1101/gad.271445.115 · Cited by 24
“A breakthrough finding in 2011 revealed that senescent cells are subject to active immune-surveillance, as CD4+T cells have been observed co-localizing with premalignant senescent cells [115].”
BackgroundPMPCB Silencing Sensitizes HCC Tumor Cells to Sorafenib Therapy
Zheng, J.-F., He, S., Zeng, Z., Gu, X., Cai, L., & Qi, G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.06.014 · Cited by 23
Martino, M. D., Tkach, M., Bruni, S., Rocha, D., Mercogliano, M. F., Cenciarini, M. E., Chervo, M. F., Proietti, C. J., Dingli, F., Loew, D., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1715767 · Cited by 24
“The SASP can either foster tumorigenesis or stimulate the innate and adaptive antitumor immune response, a process called senescence immunosurveillance.(15,16) Thus, we hypothesized that Stat3 blockade in cancer cells triggers an OIIS program able to secrete mediators that induce senescence immunosurveillance.”
BackgroundUnraveling the effect of intra- and intercellular processes on acetaminophen-induced liver injury
Heldring, M. M., Shaw, A. H., & Beltman, J. B. (2022) · npj Systems Biology and Applications · doi:10.1038/s41540-022-00238-5 · Cited by 23
Endothelial senescence mediates hypoxia-induced vascular remodeling by modulating PDGFB expression
Kyi, P., Hendee, K., Hunyenyiwa, T., Matus, K., Mammoto, T., & Mammoto, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.908639 · Cited by 27
Sugawara, S., Okada, R., Loo, T. M., Tanaka, H., Miyata, K., Chiba, M., Kawasaki, H., Katoh, K., Kaji, S., Maezawa, Y., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04369-7 · Cited by 23
Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors
Klapp, V., Buqué, A., Bloy, N., Sato, A., Yamazaki, T., Zhou, X. K., Formenti, S. C., Galluzzi, L., & Petroni, G. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03964-4 · Cited by 23
“At least in part, this may reflect the ability of M/D-driven carcinomas to evade natural killer (NK) cell-dependent immunosurveillance [43], knowing that NK cells appear to be particularly active at eliminating senescent (pre-)malignant cells [51, 52].”
BackgroundSilencing circSERPINE2 restrains mesenchymal stem cell senescence via the YBX3/PCNA/p21 axis
Chen, F., Wang, S., Zeng, C., Tang, S., Gu, H., Wang, Z., Li, J., Feng, P., Zhang, Y., Wang, P., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04975-6 · Cited by 25
“…Chen, Shan Wang and Chenying Zeng have contributed equally to this work. is recognized as an evolutionarily conserved stress response with indispensable and beneficial functions, such as preventing the propagation of damaged cells and contributing to tissue repair and tumor suppression [5, 6].”
BackgroundVenkataraman, A., Kordic, I., Li, J., Zhang, N. Y., Bharadwaj, N. S., Fang, Z., Das, S., & Coskun, A. F. (2024) · npj Aging · doi:10.1038/s41514-024-00178-w · Cited by 23
Quantifying replicative senescence as a tumor suppressor pathway and a target for cancer therapy
Rodriguez-Brenes, I. A., Wodarz, D., & Komarova, N. L. (2015) · Scientific Reports · doi:10.1038/srep17660 · Cited by 27
Hoare, M., & Narita, M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-89512-3_15 · Cited by 24
Senescent hepatocytes enhance natural killer cell activity via the CXCL‑10/CXCR3 axis
Zang, J., Ye, J., Zhang, C., Sha, M., & Gao, J. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8037 · Cited by 27
“A previous study using a mouse model reported that monocytes/macrophages orchestrated by CD4+ T cells executed the clearance of senescent hepatocytes, which inhibited the development of liver tumor (28).”
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy
Nejad, E. B., Labrie, C., Abdulrahman, Z., van Elsas, M. J., Rademaker, E., Kleinovink, J. W., van der Sluis, T. C., van Duikeren, S., Teunisse, A. F. A. S., Jochemsen, A. G., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001326 · Cited by 25
González‐Moles, M. Á., Porras‐Carrique, T. D., & Ramos‐García, P. (2023) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.25661 · Cited by 23
“In cirrhotic tissue, senescent hepatocytes release chemokines that interfere with senescence-mediated antitumor surveillance and impair immune-mediated tumor suppression (23).”
BackgroundEpigenetic Biomarker to Determine Replicative Senescence of Cultured Cells
Koch, C., & Wagner, W. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-556-9_20 · Cited by 24
Chen, K.-C., Wang, T., & Chan, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034240 · Cited by 26
Role of cellular senescence in hepatic wound healing and carcinogenesis
Ramakrishna, G., Anwar, T., Angara, R. K., Chatterjee, N., Kiran, S., & Singh, S. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2012.08.002 · Cited by 23
Reflections on the role of senescence during development and aging
Triana-Martínez, F., Pedraza-Vázquez, G., Maciel-Barón, L. Á., & Königsberg, M. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.04.004 · Cited by 24
Tsomidis, I., Tsakou, A., Voumvouraki, A., & Kouroumalis, E. (2026) · Biomedicines · doi:10.3390/biomedicines14010151 · Cited by 25
Autophagy and senescence, converging roles in pathophysiology as seen through mouse models
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2021.02.001 · Cited by 20
PPARγ attenuates cellular senescence of alveolar macrophages in asthma-COPD overlap
Wan, R., Srikaram, P., Xie, S., Chen, Q., Hu, C., Wan, M., Li, Y., & Gao, P. (2024) · Respiratory Research · doi:10.1186/s12931-024-02790-6 · Cited by 23
The impact of the senescent microenvironment on tumorigenesis: Insights for cancer therapy
Zhang, W., Zhang, K., Shi, J., Qiu, H., Kan, C., Ma, Y., Hou, N., Han, F., & Sun, X. (2024) · Aging Cell · doi:10.1111/acel.14182 · Cited by 24
Dong, X., Song, Y., Liu, Y., Kou, X., Yang, T., Shi, S. X.-Y., He, K., Li, Y., Li, Z., Yao, X., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adi6626 · Cited by 22
“NK cells can directly detect and remove senescent cells through the NKG2D receptor ( 26 , 27 ), whereas neutrophils can clear senescent cells through phagocytosis or NET formation ( 22 , 49 ).”
BackgroundMutant lamin A links prophase to a p53 independent senescence program
Moiseeva, O. V., Lessard, F., Acevedo, M., Vernier, M., Tsantrizos, Y. S., & Ferbeyre, G. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1053671 · Cited by 27
“Senescence is a promising endpoint for anticancer therapies not only due to its capability to halt cell growth but also for its ability to engage the immune system.(54,55) However, senescence can have both pro-tumor and anti-tumor effects and more work is needed to find treatments that avoid the pro-tumor activity of…”
BackgroundCotarelo, C., Schad, A., Kirkpatrick, C. J., Sleeman, J. P., Springer, E., Schmidt, M., & Thaler, S. (2016) · Oncotarget · doi:10.18632/oncotarget.12432 · Cited by 23
Zhang, S., Zeng, N., Alowayed, N., Singh, Y., Cheng, A., Lang, F. J. W., & Salker, M. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183681 · Cited by 25
Guo, G., Watterson, S., Zhang, S., Bjourson, A. J., McGilligan, V., Peace, A. J., & Singh, T. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101363 · Cited by 25
“CD4+ T cells, facilitated by macrophages, kill Nras-induced pre-malignant senescent hepatocytes (Kang et al., 2011).”
Kawata, H., Kamiakito, T., Nakaya, T., Komatsubara, M., Komatsu, K., Morita, T., Nagao, Y., & Tanaka, A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.06.007 · Cited by 22
Natural killer cells limit the clearance of senescent lung adenocarcinoma cells
Stokes, K. L., Cortez-Retamozo, V., Acosta, J., Lauderback, B., Robles-Oteiza, C., Cicchini, M., Pittet, M. J., & Feldser, D. M. (2019) · Oncogenesis · doi:10.1038/s41389-019-0133-3 · Cited by 21
The context-dependent effect of cellular senescence: From embryogenesis and wound healing to aging
Lavarti, R., Alvarez-Diaz, T., Marti, K., Kar, P., & Raju, R. P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102760 · Cited by 21
The intricate nature of senescence in development and cell plasticity
Gal, H., Majewska, J., & Krizhanovsky, V. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.01.004 · Cited by 22
Sen, B., Aggarwal, S., Nath, R., Sehgal, R., Singh, R., Agrawal, K., Shashidhara, A. N., Rastogi, A., Bajpai, M., Pamecha, V., et al. (2022) · Medical Oncology · doi:10.1007/s12032-022-01732-w · Cited by 24
“Previous reports have indicated an active role of senescent cells in chemoattracting the immune cells for its self-clearance, which is termed as senescence-surveillance [24].”
BackgroundSaleh, T., Khasawneh, A. I., Himsawi, N. M., Abu-Raideh, J. A., Ejeilat, V., Elshazly, A. M., & Gewirtz, D. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415512 · Cited by 24
Pathophysiological Roles of the cGAS-STING Inflammatory Pathway
Maekawa, H., Fain, M. E., & Wasano, K. (2023) · Physiology · doi:10.1152/physiol.00031.2022 · Cited by 24
p53 regulates diverse tissue-specific outcomes to endogenous DNA damage in mice
Hill, R. J., Bona, N., Smink, J., Webb, H. K., Crisp, A., Garaycoechea, J. I., & Crossan, G. P. (2024) · Nature Communications · doi:10.1038/s41467-024-46844-1 · Cited by 25
“Furthermore, one of the best-characterised hallmarks of aging is cellular senescence, which is not only a marker of increased age but alsooftissuedysfunction 13,70,71,75,76 .”
BackgroundGut Microbiota, Deranged Immunity, and Hepatocellular Carcinoma
Scarpellini, E., Scarlata, G. G. M., Santori, V., Scarcella, M., Kobyliak, N. M., & Abenavoli, L. (2024) · Biomedicines · doi:10.3390/biomedicines12081797 · Cited by 22
“The second step towards tumorigenesis is the imbalance and impairment of senescence surveillance by T cells on pre-malignant hepatocytes [43].”
BackgroundKooistra, S. M., Rudkjær, L. C. B., Lees, M. J., Steinhauer, C., Johansen, J. V., & Helin, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091034 · Cited by 23
“The protective effect involves immune surveillance and extensive communication of the pre-malignant senescent cells with their environment, probably through the acquisition of the senescence-associated secretory phenotype (SASP) [13,14].”
Dynamics of Senescent Cell Formation and Retention Revealed by p14ARF Induction in the Epidermis
Tokarsky-Amiel, R., Azazmeh, N., Helman, A., Stein, Y., Hassan, A., Maly, A., & Ben-Porath, I. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3730 · Cited by 21
“This stands in contrast to other previously described settings in vivo, including liver fibrosis and Ras-induced senescence, in which inflammatory cytokines recruit immune cells to rapidly remove senescent cells (13, 21, 22).”
BackgroundResultXiao, M., Chen, W., Wang, C., Wu, Y., Zhu, S., Zeng, C., Cai, Y., Liu, C., & He, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.23622 · Cited by 21
“NrasG12V-transfected mice IL-1α tumor suppression Antigen-specific CD4+ T cells secret IL-1α to exert the function of senescence surveillance [29]”
BackgroundCapone, S., Connor, K. M., Colombo, A., Li, X., Triche, T. J., & Ramsingh, G. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.03.003 · Cited by 21
Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure
Viganó, S., Bobisse, S., Coukos, G., Perreau, M., & Harari, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01350 · Cited by 24
Experiments from unfinished Registered Reports in the Reproducibility Project: Cancer Biology
Errington, T. M., Denis, A., Allison, A. B., Araiza, R., Aza-Blanc, P., Bower, L. R., Campos, J., Chu, H., Denson, S., Donham, C., et al. (2021) · eLife · doi:10.7554/elife.73430 · Cited by 23
“, 2016]), or the expression had not occurred at detectable levels or were already cleared despite following the same timing as the original study (Kang et al., 2011).”
BackgroundResultInfluentialTargeting KRAS in pancreatic cancer: Emerging therapeutic strategies
Khan, S. U., Budamagunta, V., & Zhou, D. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2023.02.004 · Cited by 23
Self-citationQuantitative Analysis of Cellular Senescence in Culture and In Vivo
Zhao, J., Fuhrmann‐Stroissnigg, H., Gurkar, A. U., Flores, R. R., Dorronsoro, A., Stolz, D. B., Croix, C. M. S., Niedernhofer, L. J., & Robbins, P. D. (2017) · Current Protocols in Cytometry · doi:10.1002/cpcy.16 · Cited by 23
Jiang, X., Baig, A. H., Palazzo, G., Pizzo, R. D., Borteçen, T., Groessl, S., Zaal, E. A., Ramirez, C. C. A., Kowar, A., Huerta, D. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51901-w · Cited by 22
“To this end, weemployed a well-established in vivo model for OIS 5,45 .”
Wong, P. Y., Chan, C. Y. K., Xue, H. D. G., Goh, C. C., Cheu, J. W., Tse, A. P., Zhang, M. S., Zhang, Y., & Wong, C. C. (2024) · JCI Insight · doi:10.1172/jci.insight.170532 · Cited by 22
Santamaria, J. C., & Irla, M. (2026) · Science Advances · doi:10.1126/sciadv.aeb2970 · Cited by 23
“In addition to their protective roles against infections and cancer, T cells have been shown to recognize and eliminate senescent cells ( 15 , 18 – 21 ).”
Metadata
- Authors
- Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., Iken, M., Vucur, M., Weiss, S., Heikenwalder, M., Khan, S., Gil, J., Bruder, D., Manns, M., Schirmacher, P., Tacke, F., Ott, M., Luedde, T., Longerich, T., Kubicka, S., & Zender, L.
- Affiliations
- Helmholtz Centre for Infection Research (DE)
- Medizinische Hochschule Hannover (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Universitätsklinikum Aachen (DE)
- Imperial College London (GB)
- Heidelberg University (DE)
- Kreiskliniken Reutlingen (DE)
- Corresponding author
- Zender, Lars
- ORCID
- Venue
- Nature
- Published
- 2011-11
- Volume
- 479
- Issue
- 7374
- Pages
- 547-551
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2042140414
- Cited by
- 1,621
- References
- 22
- Citations by year
- 2026: 93 · 2025: 127 · 2024: 154 · 2023: 140 · 2022: 148 · 2021: 139 · 2020: 137 · 2019: 103 · 2018: 110 · 2017: 99 · 2016: 84 · 2015: 78 · 2014: 72 · 2013: 84 · 2012: 49
- FWCI
- 45.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- oncogene-induced senescence, cellular senescence, hepatocytes, hepatocellular carcinoma, tumor surveillance, CD4+ T cells, tumor antigens, Th1 cells, monocytes/macrophages, tumor suppression, cancer prevention, cancer vaccines
- MeSH terms
- Animals, Antigens, Neoplasm, Carcinoma, Hepatocellular, Humans, Immunologic Surveillance, Liver, Liver Neoplasms, Phagocytosis, Precancerous Conditions, Genes, ras, CD4-Positive T-Lymphocytes, Mice, SCID, Cellular Senescence, Disease Progression, Cancer Vaccines, Hepatocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.